Final Programme 2015

educational goals

Friday, 29 May 2015

ADHD rated their daily inattentiveness, hyperactivity, and

impulsivity (Conners, 2008; Döpfner, Görtz-Dorten, Lehm-

kuhl, Breuer, & Goletz, 2008) on eight consecutive days.

By means of intra-class correlation coefficients and mul-

tilevel confirmatory factor analyses we analyzed symptom

fluctuations and symptom factor structure both on the

trait-like between-person level (i.e., averaged across days)

and on the within-person level.

The results replicate previous findings supporting both

unity and diversity among symptoms on a trait-like bet-

ween-person level with the superior fit of hierarchical mo-

dels. The unique contribution of our study is that we de-

monstrate substantial within-person symptom fluctuations

that are represented best by a within-person factor struc-

ture resembling the hierarchical between-person factor

structure. Practical and theoretical implications of the am-

bulatory assessment of ADHD symptoms (inattention, hy-

peractivity, impulsivity) and its correlates as for instance

cognitive functions, motivation, and activity will be dis-

cussed, taking into account possible influences of daily

environmental variations.

ES-3

Educational Seminar

17.00–18.00 h

Clyde Auditorium

New assessment strategies of ADHD in adults

Chairs: A. Philipsen, Germany

W. Retz, Germany

The diagnosis of Attention-Deficit/Hyperactivity Disorder

(ADHD) in adults is a complex process especially if the dis-

order was not diagnosed during childhood. Different data-

bases and data sources have to be considered. The semi-

nar provides an overview of general problems of the

assessment, the different steps of the diagnostic process

and the instruments which can be useful to diagnose adult

ADHD. Available are interviews, self and observer rating

scales. Finally some unsolved issues in the assessment of

ADHD in adults are discussed.

ES-4

Educational Seminar

17.00–18.00 h

Lomund Auditorium

To treat or not to treat - controversies and

difficulties related to treatment of this population –

psychosocial treatment, what do we know?

Chairs: J. A. Ramos-Quiroga, Spain

G. van de Glind, The Netherlands

Purpose of the seminar:

To review the management of

ADHD with SUD.

Description of the seminar content:

During the last for-

ty years there has been an increasing level of evidence that

ADHD affects adults. The prevalence of ADHD in adults is

significantly higher within clinical samples compared to

the results obtained from studies within the general popu-

lation. The prevalence of ADHD in adults is significantly

higher within clinical samples compared to the results ob-

tained from studies within the general population. In the

first multinational study on the prevalence of ADHD in

treatment-seeking SUD adult patients, based on the DSM-

IV criteria, adult ADHD varied between countries, from 5.4%

(95% CI : 2.4-8.3 ) in Hungary to 31.3 % (95% CI : 25.2-

37.5) in Norway. The new version, DSM-5, makes more

explicit references to the progression of ADHD into adult-

hood, adapting the current criteria to the disorder’s evolu-

tionary reality. In order to assess the comorbidity of ADHD

in adults there are useful interviews, including the Psychi-

atric Research Interview for Substance and Mental Disor-

ders IV (PRISM-IV) and the Mini International Neuropsychi-

atric Interview-Plus (MINI-Plus). The drugs indicated for the

treatment of ADHD in adults are the same to those recom-

mended for children and adolescents. There have been

many more clinical trials evaluating the efficacy and safety

of the drugs used in ADHD treatment on children than

adults. It is important to highlight the positive impact of

ADHD treatment for adults in terms of improving aspects

of their daily functioning.

Audience to be addressed:

Clinicians and biologists